On April 23, the People's Pharmacy Chain Co., Ltd. (603883. SH, hereinafter referred to as "People's Pharmacy") ushered in the ninth anniversary of its listing on the main board of Shanghai.
In recent years, focusing on the core strategy of "building a technology-driven health service platform", the people's pharmacy has deeply focused on customer needs, actively explored and iterated the digital and intelligent transformation of enterprises, and steadily improved the company's operating quality.
01
The performance continues to climb and high dividends are returned to shareholders
Since its listing in 2015, Laobaimin Pharmacy has achieved both operating income and net profit attributable to the parent company for 8 consecutive years, showing a steady and strong development trend.
According to the data, from 2015 to 2022, the compound annual growth rate of the revenue of the people's pharmacy will reach 23.64%, and the compound annual growth rate of net profit attributable to the parent company will be 18.41%. The company's operating income in the first three quarters of 2023 was 16.042 billion yuan, a year-on-year increase of 16.44%, and the net profit attributable to the parent company was 717 million yuan, a year-on-year increase of 17.54%.
The company continues to build a "troika" three-dimensional deep cultivation model of "direct sales + mergers and acquisitions + franchise + alliance" to expand rapidly, actively sink the market, and promote the equality of regional pharmaceutical resources. From 2015 to 2022, the compound annual growth rate of the company's stores reached 32.77%. As of the end of the third quarter of 2023, the number of Lao Baimin Pharmacy stores has exceeded 13,000, and the scale of stores continues to maintain a leading position.
It is worth mentioning that while the performance continues to grow, the People's Pharmacy cares about its shareholders, and has distributed equity for 8 consecutive years since its listing, with a cumulative cash dividend of 1.37 billion yuan, and the total cash dividend amount from 2015 to 2022 is 136% of the net funds raised by the listed offering. Among them, the company distributed a total of 292 million yuan in cash dividends in 2022, accounting for 37.25% of the net profit attributable to the parent company in 2022.
02
The results of digital and intelligent transformation are highlighted, and the implementation of outpatient co-ordination policies has accelerated
With the advent of the digital wave, the people's pharmacies have moved with the times, firmly and rapidly promoted the digital and intelligent transformation of enterprises, actively promoted the transformation of enterprises from traditional pharmaceutical retail to digital intelligence and omni-channel, and gradually built a traditional chain pharmacy into a pioneer and model of digital and intelligent transformation in the retail industry.
Since 2019, the company has continued to increase investment from a strategic height, actively built an enterprise digital intelligence platform, empowered the front, middle and back office business processes through digital intelligence technology, built a full-link digital intelligence system of "operation, procurement, commerce and sales" of the enterprise, and continuously strengthened the refined management of "people, goods and fields". The company has self-developed digital and intelligent tools such as intelligent requisition and intelligent drug recommendation, laid Bluetooth intelligent testing equipment in 10,000 stores across the country, innovated a new retail model integrating customer drug purchase experience and health management, and optimized customer experience and satisfaction while continuously improving operational efficiency.
At the same time, with the further liberalization of pharmacies and the acceleration of the circulation of electronic prescriptions under the outpatient co-ordination policy, more patients will be guided to flow to social pharmacies and the transformation and upgrading of retail pharmacies will be promoted. The people's pharmacy grasps the implementation of the policy and supports the operation and implementation through the three-dimensional "policy + system + data". As of the end of the third quarter of 2023, among the 18 provinces covered by the company's network, the outpatient co-ordination policy has been implemented in 14 provinces, with a total of 2,893 swipeable and mutual stores nationwide, accounting for 22.14% of the company's total stores. The company said that from the data point of view, in 2023, the company's retail pharmacies that have been included in the overall management of outpatient clinics will have a significant increase in the number of visitors and sales compared with those that have not landed in stores.
Xie Zilong, chairman of the company, said that from selling a box of medicine to building long-term health management services, the people's pharmacy has always insisted on doing a good job of "health" step by step. In the future, the company will continue to deepen the health service ecology, deeply focus on customer needs, accelerate the construction of a technology-driven health service platform, continue to create value to return to the majority of shareholders, and contribute more warm and professional "healing" power to the people's better life.
END